BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5373894)

  • 1. Increased selectivity of interaction between fluorenylamine carcinogens and liver proteins during hepatocarcinogenesis.
    Sorof S; Young EM; McBride RZ; Coffey CB; Luongo L
    Mol Pharmacol; 1969 Nov; 5(6):625-39. PubMed ID: 5373894
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of liver regeneration on the loss of fluorenylacetamide derivative bound to liver DNA.
    Witschi H; Epstein SM; Farber E
    Cancer Res; 1971 Mar; 31(3):270-3. PubMed ID: 5547215
    [No Abstract]   [Full Text] [Related]  

  • 3. On protein targets of chemical carcinogens: dissimilar molecular sizes of the principal protein conjugates.
    Sorof S; Young EM; McBride RA; Coffey CB
    Cancer Res; 1970 Jul; 30(7):2029-34. PubMed ID: 4989548
    [No Abstract]   [Full Text] [Related]  

  • 4. The binding of 2-acetylaminofluorene to rat liver ribonucleic acid in vivo.
    Marroquin F; Farber E
    Cancer Res; 1965 Sep; 25(8):1262-9. PubMed ID: 5839718
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of continuously fed 14C-labeled N-hydroxy-N-2-fluorenylacetamide at various intervals: effect of pituitary hormones.
    Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH
    Cancer Res; 1967 May; 27(5):865-72. PubMed ID: 4290554
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of L-asparaginase on mitotic activity during N-2-fluorenylacetamide hepatocarcinogenesis: subpopulations of nodular cells.
    Becker FF; Klein KM
    Cancer Res; 1971 Feb; 31(2):169-73. PubMed ID: 5545268
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of 3-methylcholanthrene and diet on the binding of 2-acetylaminofluroene and its N-hydroxy metabolite to rat liver nucleic acids.
    Irving CC; Peeler TC; Veazey RA; Wiseman R
    Cancer Res; 1971 Oct; 31(10):1468-72. PubMed ID: 5095133
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding of chemical carcinogens to nuclear proteins of rat liver.
    Jungmann RA; Schweppe JS
    Cancer Res; 1972 May; 32(5):952-9. PubMed ID: 4622840
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Stout DL; Becker FF
    Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination of enzyme histochemistry and radioautography: a new method applied to analysis of hepatocarcinogenesis.
    Kitagawa T; Sugano H
    Gan; 1972 Aug; 63(4):509. PubMed ID: 5081629
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioactivity in rat mammary gland after the administration of 2-acetylaminofluorene-9- 14 C and its N-hydroxy metabolite.
    Janss DH; Irving CC
    J Natl Cancer Inst; 1972 Sep; 49(3):765-71. PubMed ID: 4647496
    [No Abstract]   [Full Text] [Related]  

  • 12. Preferential binding of 2-acetylaminofluorene to rat liver rRNA during early stages of hepatocarcinogenesis.
    Irving CC; Veazey RA
    Biochem Biophys Res Commun; 1972 Jun; 47(5):1159-64. PubMed ID: 5029863
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo.
    Kriek E
    Cancer Res; 1972 Oct; 32(10):2042-8. PubMed ID: 5080759
    [No Abstract]   [Full Text] [Related]  

  • 14. The reaction of specific antibody with 2-acetylaminofluorene fixed in liver cells.
    Tanigaki N; Kitagawa M; Yagi Y; Pressman D
    Cancer Res; 1967 Apr; 27(4):747-51. PubMed ID: 4290626
    [No Abstract]   [Full Text] [Related]  

  • 15. Localization of alpha-fetoprotein by immunofluorescence in hyperplastic nodules during hepatocarcinogenesis induced by 2-acetylaminofluorene.
    Okita K; Gruenstein M; Klaiber M; Farber E
    Cancer Res; 1974 Oct; 34(10):2758-63. PubMed ID: 4370173
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal's gland of the rat.
    Irving CC; Janss DH; Russell LT
    Cancer Res; 1971 Apr; 31(4):387-91. PubMed ID: 5553685
    [No Abstract]   [Full Text] [Related]  

  • 17. Depression of enzymic esterification of N-hydroxy-AAF in the liver during aminoazo dye carcinogenesis in the rat.
    Blunck JM; Lees BJ
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):421-9. PubMed ID: 4699475
    [No Abstract]   [Full Text] [Related]  

  • 18. Further evidence for two types of adducts of N-hydroxy-2-fluorenylacetamide with rat-liver proteins.
    Barry EJ; Gutmann HR
    Chem Biol Interact; 1970 Aug; 2(2):158-9. PubMed ID: 5526729
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic controls in precancerous liver: defective control of cholesterol synthesis in rats fed N-2-fluorenylacetamide.
    Horton BJ; Sabine JR
    Eur J Cancer (1965); 1971 Oct; 7(5):459-65. PubMed ID: 4334170
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of 5-fluorodeoxyuridine on the synthesis of deoxyribonucleic acid pyrimidines in precancerous rat liver.
    Goodman JI; Potter VR
    Mol Pharmacol; 1973 May; 9(3):297-303. PubMed ID: 4267955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.